Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 1

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-60805-857-0 (Print)
ISBN: 978-1-60805-856-3 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080585631140101


Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The first volume of this series features 6 chapters that cover a variety of topics including:

  • - Angiotensin blockers
  • - Agents targeting advanced glycation end products
  • - Drugs and the peroxisome proliferator activated receptors
  • - Topical Drugs for diabetic complications
  • - Research on Liraglutide
  • - Research on MicroRNAs as agents for diabetes treatment


- Pp. i-iii (3)
Download Free

List of Contributors

- Pp. iv-v (2)
Download Free

Angiotensin Blockers and Renoprotection in Diabetic Chronic Kidney Disease is a Failed Paradigm? – A Revisionist View of Renoprotection in Diabetic Chronic Kidney Disease and A Novel Classification Scheme for Renoprotective Agents

- Pp. 3-32 (30)
Macaulay A.C. Onuigbo
View Abstract

New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)

- Pp. 33-66 (34)
Emilia Liao, Agustin Busta, Ashutosh Pareek, Leonid Poretsky
View Abstract

Liraglutide: Present and Future

- Pp. 67-120 (54)
Dan Mircea Cheţa, Cristian Serafinceanu, Cornelia Zetu
View Abstract

MicroRNA, A Diligent Conjurer in the Exposition of Diabetes

- Pp. 121-148 (28)
Puneetpal Singh
View Abstract

Drugs and the Peroxisome Proliferator Activated Receptors

- Pp. 149-210 (62)
Kevin Stuart, Andrew Hartland, Mithun Bhartia, Sudarshan Ramachandran
View Abstract

Topical Drugs for Diabetic Complications Current and Future

- Pp. 211-288 (78)
Ryuhei Sano, Tomohiko Sasase
View Abstract


- Pp. 289-309 (21)
Download Free


.Nanoscience Applications in Diabetes Treatment.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Diabesity: A Multidisciplinary Approach.
.Pharmacological and Molecular Perspectives on Diabetes.